Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vaccine
Biotech
Sanofi pays $175M for J&J's late-phase E. coli vaccine
As Johnson & Johnson retreats from the vaccine sector, Sanofi is gambling $175 million on the healthcare giant's late-phase E. coli vaccine.
Nick Paul Taylor
Oct 3, 2023 7:32am
Arcturus sa-mRNA COVID boosters induce immune response in ph. 2
Sep 19, 2023 11:40am
Variant vulnerability vanquishes Bavarian Nordic's COVID vaccine
Sep 1, 2023 5:39am
FDA delays decision on Valneva's chikungunya vaccine by 3 months
Aug 14, 2023 6:00am
Bavarian Nordic flags COVID shot 'concern' before phase 3 data
Jun 16, 2023 6:45am
Pfizer's maternal RSV vaccine filing sets up AZ, Sanofi showdown
Feb 21, 2023 9:15am